- Home
- SMSI vs PYPD Comparison
SMSI vs PYPD Comparison
Compare SMSI & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMSI
- PYPD
- Stock Information
- Founded
- SMSI 1982
- PYPD 2008
- Country
- SMSI United States
- PYPD Israel
- Employees
- SMSI N/A
- PYPD N/A
- Industry
- SMSI Computer Software: Prepackaged Software
- PYPD Medical/Dental Instruments
- Sector
- SMSI Technology
- PYPD Health Care
- Exchange
- SMSI Nasdaq
- PYPD Nasdaq
- Market Cap
- SMSI 16.2M
- PYPD 16.5M
- IPO Year
- SMSI 1995
- PYPD 2020
- Fundamental
- Price
- SMSI $0.96
- PYPD $2.93
- Analyst Decision
- SMSI Strong Buy
- PYPD Strong Buy
- Analyst Count
- SMSI 1
- PYPD 2
- Target Price
- SMSI $5.00
- PYPD $12.00
- AVG Volume (30 Days)
- SMSI 242.1K
- PYPD 28.7K
- Earning Date
- SMSI 11-13-2024
- PYPD 02-12-2025
- Dividend Yield
- SMSI N/A
- PYPD N/A
- EPS Growth
- SMSI N/A
- PYPD N/A
- EPS
- SMSI N/A
- PYPD N/A
- Revenue
- SMSI $24,178,000.00
- PYPD N/A
- Revenue This Year
- SMSI N/A
- PYPD N/A
- Revenue Next Year
- SMSI $62.34
- PYPD N/A
- P/E Ratio
- SMSI N/A
- PYPD N/A
- Revenue Growth
- SMSI N/A
- PYPD N/A
- 52 Week Low
- SMSI $0.52
- PYPD $2.37
- 52 Week High
- SMSI $7.52
- PYPD $9.20
- Technical
- Relative Strength Index (RSI)
- SMSI 61.96
- PYPD 33.37
- Support Level
- SMSI $0.72
- PYPD $2.37
- Resistance Level
- SMSI $0.90
- PYPD $3.13
- Average True Range (ATR)
- SMSI 0.10
- PYPD 0.24
- MACD
- SMSI 0.03
- PYPD -0.06
- Stochastic Oscillator
- SMSI 68.91
- PYPD 19.30
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. It offers multi-platform, modular solutions such as SafePath; CommSuite; and ViewSpot. The company's only reportable segment is Wireless. Its Wireless segment sells to large wireless carriers, cable operators, and OEMs.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.